Dai Ohno Selected Research

Dai Ohno Research Topics

6	Chronic Renal Insufficiency 03/2014 - 01/2012
2	Glomerulonephritis 01/2015 - 11/2013
2	Proteinuria 01/2015 - 11/2013
2	Hypertension (High Blood Pressure) 01/2013 - 01/2012
1	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2015
1	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 01/2015
1	Cryoglobulinemia 01/2015
1	Disseminated Intravascular Coagulation 01/2015
1	Hemorrhage 01/2015
1	Secondary Hyperparathyroidism 04/2014
1	Hyperuricemia 03/2014
1	Type 2 Diabetes Mellitus (MODY) 01/2014
1	Hypernatremia 12/2013
1	Heart Failure 12/2013
1	Acute Kidney Injury (Acute Renal Failure) 01/2012
1	Rheumatoid Arthritis 06/2009

2	SteroidsIBA 01/2015 - 11/2013
1	RNA (Ribonucleic Acid)IBA 01/2015
1	CreatinineIBA 01/2015
1	CryoglobulinsIBA 01/2015
1	InterferonsIBA 01/2015
1	Phosphates (Orthophosphate)IBA 04/2014
1	CalciumIBA 04/2014
1	Vitamin D FDA LinkGeneric 04/2014
1	Xanthine OxidaseIBA 03/2014
1	Uric Acid (Urate)IBA 03/2014
1	Allopurinol (Remid)FDA LinkGeneric 03/2014
1	Febuxostat FDA Link 03/2014
1	alogliptinIBA 01/2014
1	Tolvaptan FDA Link 12/2013
1	DiureticsIBA 12/2013
1	Immunoglobulins (Immunoglobulin)IBA 11/2013
1	Immunoglobulin G (IgG)IBA 11/2013
1	Prednisolone (Predate)FDA LinkGeneric 11/2013
1	Therapeutic UsesIBA 01/2013
1	olmesartanIBA 01/2013
1	Antihypertensive Agents (Antihypertensives)IBA 01/2012
1	aliskiren FDA Link 01/2012
1	Infliximab (Remicade)FDA Link 06/2009
1	Pharmaceutical PreparationsIBA 06/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2009

1	Therapeutics 01/2015
1	Glycemic Control 01/2014
1	Blood Component Removal (Apheresis) 01/2012